Loading…
Sectoral / Thematic · UTI Mutual Fund · AMFI code 100806UTI - Healthcare Fund
Disclosed for 95 months, Jul 2017 to Sep 2026.
Portfolio value
₹683 Cr
down ₹23 Cr vs May 2022
- Stocks held
- 33
- unchanged
- Top 10 weight
- 57.3%
- of the portfolio in its ten largest
- Cash & debt
- 1.9%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 20
UTI - Healthcare Fund is an active equity fund in the Sectoral / Thematic category from UTI Mutual Fund. In June 2022 it disclosed 33 stocks worth ₹683 Cr, down ₹23 Cr from May 2022. Its largest positions were Sun Pharmaceutical Industries Limited (11.0%), Dr. Reddy's Laboratories Limited (9.5%), Cipla Limited (7.9%); the ten largest together made up 57.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 80.0% of its equity. Cash and debt stood at 1.9%. Compared with May 2022 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
76%
Top-10 weight is higher than 76% of peers
Breadth
19%
Holds more stocks than 19% of peers
Cash
28%
Holds more cash than 28% of peers
What these mean: concentration · cash
Holdings in June 2022
Download CSVEvery line the fund disclosed, with the change against May 2022. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 11.04% | down 0.03 pts | ₹75.4 Cr | down ₹2.7 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited | 9.53% | up 0.36 pts | ₹65.1 Cr | up ₹36 L | Added |
| Cipla Limited | 7.94% | down 0.67 pts | ₹54.3 Cr | down ₹6.5 Cr | Trimmed |
| Fortis Healthcare Limited | 4.80% | up 0.10 pts | ₹32.8 Cr | down ₹38 L | Trimmed |
| Divi's Laboratories Limited | 4.57% | up 0.20 pts | ₹31.2 Cr | up ₹34 L | Added |
| Aurobindo Pharma Limited | 4.38% | down 0.05 pts | ₹29.9 Cr | down ₹1.4 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 4.00% | up 0.64 pts | ₹27.3 Cr | up ₹3.6 Cr | Added |
| Ajanta Pharma Limited | 3.75% | up 0.40 pts | ₹25.6 Cr | up ₹1.9 Cr | Added |
| IPCA Laboratories Limited | 3.69% | up 0.11 pts | ₹25.3 Cr | down ₹5 L | Held |
| Eris Lifesciences Limited | 3.64% | up 0.12 pts | ₹24.9 Cr | down ₹2 L | Held |
| Krishna Institute Of Medical Sciences Limited | 3.51% | down 0.78 pts | ₹24 Cr | down ₹6.3 Cr | Trimmed |
| Zydus Lifesciences Limited | 3.38% | up 0.07 pts | ₹23.1 Cr | down ₹28 L | Trimmed |
| Biocon Limited | 3.04% | down 0.59 pts | ₹20.8 Cr | down ₹4.9 Cr | Trimmed |
| Lupin Limited | 2.88% | down 0.38 pts | ₹19.7 Cr | down ₹3.4 Cr | Trimmed |
| Torrent Pharmaceuticals Limited | 2.55% | up 0.31 pts | ₹17.5 Cr | up ₹1.6 Cr | Added |
| Gland Pharma Limited | 2.41% | up 0.15 pts | ₹16.5 Cr | up ₹53 L | Added |
| Suven Pharmaceuticals Limited | 2.11% | down 0.10 pts | ₹14.4 Cr | down ₹1.2 Cr | Trimmed |
| Abbott India Limited | 2.05% | up 0.35 pts | ₹14 Cr | up ₹2 Cr | Added |
| JB Chemicals & Pharmaceuticals Limited | 1.98% | up <0.01 pts | ₹13.5 Cr | down ₹46 L | Trimmed |
| Alkem Laboratories Limited | 1.97% | down 0.03 pts | ₹13.5 Cr | down ₹68 L | Trimmed |
| Procter & Gamble Health Limited | 1.69% | up 0.08 pts | ₹11.6 Cr | up ₹14 L | Added |
| Cash, TREPS & receivables | 1.67% | up 0.18 pts | ₹11.4 Cr | up ₹89 L | Added |
| Alembic Pharmaceuticals Limited | 1.65% | up 0.05 pts | ₹11.2 Cr | down ₹6 L | Trimmed |
| Poly Medicure Limited | 1.64% | up 0.06 pts | ₹11.2 Cr | up ₹2 L | Held |
| Narayana Hrudayalaya Limited | 1.46% | down 0.09 pts | ₹10 Cr | down ₹94 L | Trimmed |
| Pfizer Limited | 1.41% | down 0.34 pts | ₹9.6 Cr | down ₹2.7 Cr | Trimmed |
| Rainbow Childrens Medicare Limited | 1.37% | down 0.04 pts | ₹9.4 Cr | down ₹63 L | Trimmed |
| Metropolis Healthcare Limited | 1.28% | down 0.14 pts | ₹8.8 Cr | down ₹1.3 Cr | Trimmed |
| Acutaas Chemicals Limited | 1.24% | down 0.09 pts | ₹8.5 Cr | down ₹90 L | Trimmed |
| Advanced Enzyme Technologies Limited | 0.99% | down 0.14 pts | ₹6.8 Cr | down ₹1.2 Cr | Trimmed |
| Sequent Scientific Limited | 0.84% | down 0.13 pts | ₹5.8 Cr | down ₹1.1 Cr | Trimmed |
| WINDLAS BIOTEC LTD | 0.57% | down <0.01 pts | ₹3.9 Cr | down ₹16 L | Trimmed |
| Indoco Remedies Limited | 0.53% | up 0.21 pts | ₹3.6 Cr | up ₹1.4 Cr | Added |
| Natco Pharma Limited | 0.22% | up 0.20 pts | ₹1.5 Cr | up ₹1.4 Cr | Added |
| T BILL RESERVE BANK OF INDIA Debt | 0.20% | up 0.01 pts | ₹1.3 Cr | up ₹1 L | Held |
What changed, May 2022 to Jun 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Apollo Hospitals Enterprise Limitedup ₹3.6 Cr (+0.64% pts)
- Abbott India Limitedup ₹2 Cr (+0.35% pts)
- Ajanta Pharma Limitedup ₹1.9 Cr (+0.40% pts)
- Torrent Pharmaceuticals Limitedup ₹1.6 Cr (+0.31% pts)
- Natco Pharma Limited ₹1.4 Cr (+0.20% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since May 2022, the weight rose most in Pharmaceuticals (+0.2 pts) and Pharmaceuticals & Biotechnology (+0.1 pts), and fell most in Healthcare Services (−0.3 pts) and Consumer Non Durables (−0.1 pts).
- Pharmaceuticals0.3% → 0.5%+0.2 pts
- Pharmaceuticals & Biotechnology79.9% → 80.0%+0.1 pts
- Healthcare Services17.0% → 16.7%−0.3 pts
- Consumer Non Durables1.1% → 1.0%−0.1 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jun 2019 | Jun 2021 | Dec 2021 | Mar 2022 | May 2022 | Jun 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 89.1% | 79.2% | 79.4% | 79.2% | 79.9% | 80.0% |
| Healthcare Services | 10.9% | 16.7% | 17.2% | 17.7% | 17.0% | 16.7% |
| Healthcare Equipment & Supplies | — | 1.7% | 1.7% | 1.9% | 1.6% | 1.7% |
| Consumer Non Durables | — | 2.4% | 1.8% | 1.3% | 1.1% | 1.0% |
| Pharmaceuticals | — | — | — | — | 0.3% | 0.5% |
Allocation in Jun 2022change vs May 2022
- Pharmaceuticals & Biotechnology (24)80.0%▲ 0.1 pts
- Healthcare Services (6)16.7%▼ 0.3 pts
- Healthcare Equipment & Supplies (1)1.7%▲ 0.1 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jun 2022
1.9%
▲ 0.2 pts vs May 2022
- Cash alone
- 1.7%
- cash and net receivables
- A year earlier
- 2.2%
- Jun 2021 · now ▼ 0.3 pts
- Last 12 months
- 1.7% – 3.3%
- lowest to highest · record 7.3% in Jul 2017
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.